Literature DB >> 26178038

Quantitative molecular imaging of cardiac amyloidosis: The journey has begun.

Sharmila Dorbala1,2,3, Marie Foley Kijewski4, Mi-Ae Park4.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26178038     DOI： 10.1007/s12350-015-0235-z

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  16 in total

1.  Light chain amyloidosis: the heart of the problem.

Authors:  Giampaolo Merlini; Giovanni Palladini
Journal:  Haematologica       Date:  2013-10       Impact factor: 9.941

2.  Accurate analysis and visualization of cardiac (11)C-PIB uptake in amyloidosis with semiautomatic software.

Authors:  Tanja Kero; Lars Lindsjö; Jens Sörensen; Mark Lubberink
Journal:  J Nucl Cardiol       Date:  2015-07-15       Impact factor: 5.952

3.  Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.

Authors:  François-Pierre Mongeon; Michael Jerosch-Herold; Otávio Rizzi Coelho-Filho; Ron Blankstein; Rodney H Falk; Raymond Y Kwong
Journal:  JACC Cardiovasc Imaging       Date:  2012-09

4.  Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios.

Authors:  Susan M Landau; Allison Fero; Suzanne L Baker; Robert Koeppe; Mark Mintun; Kewei Chen; Eric M Reiman; William J Jagust
Journal:  J Nucl Med       Date:  2015-03-05       Impact factor: 10.057

5.  In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET.

Authors:  Gunnar Antoni; Mark Lubberink; Sergio Estrada; Jan Axelsson; Kristina Carlson; Lars Lindsjö; Tanja Kero; Bengt Långström; Sven-Olof Granstam; Sara Rosengren; Ola Vedin; Cecilia Wassberg; Gerhard Wikström; Per Westermark; Jens Sörensen
Journal:  J Nucl Med       Date:  2012-12-13       Impact factor: 10.057

6.  Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.

Authors:  Giovanni Palladini; Carlo Campana; Catherine Klersy; Alessandra Balduini; Giovanbattista Vadacca; Vittorio Perfetti; Stefano Perlini; Laura Obici; Edoardo Ascari; Gianvico Melzi d'Eril; Remigio Moratti; Giampaolo Merlini
Journal:  Circulation       Date:  2003-04-28       Impact factor: 29.690

7.  11C-Pittsburgh B PET imaging in cardiac amyloidosis.

Authors:  Seung-Pyo Lee; Eun Seong Lee; Hongyoon Choi; Hyung-Jun Im; Youngil Koh; Min-Ho Lee; Ji-Hyun Kwon; Jin Chul Paeng; Hyung-Kwan Kim; Gi Jeong Cheon; Yong-Jin Kim; Inho Kim; Sung-Soo Yoon; Jeong-Wook Seo; Dae-Won Sohn
Journal:  JACC Cardiovasc Imaging       Date:  2014-11-04

8.  Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement.

Authors:  Shira Dinner; Wesley Witteles; Anosheh Afghahi; Ronald Witteles; Sally Arai; Richard Lafayette; Stanley L Schrier; Michaela Liedtke
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

9.  T1 mapping and survival in systemic light-chain amyloidosis.

Authors:  Sanjay M Banypersad; Marianna Fontana; Viviana Maestrini; Daniel M Sado; Gabriella Captur; Aviva Petrie; Stefan K Piechnik; Carol J Whelan; Anna S Herrey; Julian D Gillmore; Helen J Lachmann; Ashutosh D Wechalekar; Philip N Hawkins; James C Moon
Journal:  Eur Heart J       Date:  2014-11-16       Impact factor: 29.983

10.  A Routine PET/CT Protocol with Streamlined Calculations for Assessing Cardiac Amyloidosis Using (18)F-Florbetapir.

Authors:  Dustin R Osborne; Shelley N Acuff; Alan Stuckey; Jonathan S Wall
Journal:  Front Cardiovasc Med       Date:  2015-05-08
View more
  7 in total

Review 1.  Review of cardiovascular imaging in the journal of nuclear cardiology in 2015. Part 1 of 2: Plaque imaging, positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-11-05       Impact factor: 5.952

Review 2.  Review of Cardiovascular Imaging in the Journal of Nuclear Cardiology in 2016. Part 1 of 2: Positron Emission Tomography, Computed Tomography and Magnetic Resonance.

Authors:  Wael AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-02-13       Impact factor: 5.952

Review 3.  Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.

Authors:  Paco E Bravo; Sharmila Dorbala
Journal:  Curr Cardiol Rep       Date:  2017-07       Impact factor: 2.931

4.  Nuclear imaging of cardiac amyloidosis. 'We've only just begun'.

Authors:  Pradeep Bhambhvani; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2016-09-08       Impact factor: 5.952

5.  Significance of 11C-PIB PET/CT in cardiac amyloidosis compared with 99mTc-aprotinin scintigraphy: A pilot study.

Authors:  Ryogo Minamimoto; Toru Awaya; Kentaro Iwama; Masatoshi Hotta; Kazuhiko Nakajima; Risen Hirai; Osamu Okazaki; Yukio Hiroi
Journal:  J Nucl Cardiol       Date:  2018-03-27       Impact factor: 5.952

Review 6.  Multimodality Imaging in the Evaluation and Management of Cardiac Amyloidosis.

Authors:  Yiu Ming Khor; Sarah Cuddy; Rodney H Falk; Sharmila Dorbala
Journal:  Semin Nucl Med       Date:  2020-02-09       Impact factor: 4.802

7.  Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using 18F-Florbetapir PET/CT.

Authors:  Ariana Nodoushani; Mohammed Samir El-Sady; Mi-Ae Park; Gloria L Castilloveitia; Rodney H Falk; Marcelo F Di Carli; Marie Foley Kijewski; Sharmila Dorbala
Journal:  J Nucl Cardiol       Date:  2019-11-22       Impact factor: 3.872
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.